Alexandra Barbera
Medical · Greensburg, PANPI 1467064956
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.6% of the total across 1,453 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,453 payments — averaging $22.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- EMD Serono, Inc.$2K
- Acadia Pharmaceuticals Inc$2K
- Livanova USA, Inc.$2K
- Teva Pharmaceuticals USA, Inc.$2K
- Novartis$2K
- plus $20K from 54 others
What the payments were for
- Speaking & faculty fees$1861%
- Travel & lodging$2,0776%
- Food & beverage$30,54792%
- Education$5232%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$1,158
- VERCISE$1,156
- NUPLAZID$565
- VNS - Sentiva$527
- Mavenclad$347
- Epidiolex$271
- QULIPTA$250
- Briviact$243
- Austedo XR$241
- Vumerity$238
- XCOPRI$229
- Ponvory$213
- GENERAL DBS$147
- REXULTI$125
- UPLIZNA$125
- KESIMPTA$123
- BRIUMVI$115
- TYSABRI$113
- OCREVUS$112
- VALTOCO$107
How this compares
$33,333 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 15 | $202,788 |
| NuplazidPimavanserin Tartrate | 39 | $186,793 |
| AustedoDeutetrabenazine | 14 | $137,134 |
| Kesimpta PenOfatumumab | 13 | $130,364 |
| Nurtec OdtRimegepant Sulfate | 110 | $128,288 |
| IngrezzaValbenazine Tosylate | 14 | $101,330 |
| EpidiolexCannabidiol (Cbd) | 12 | $90,954 |
| Aimovig AutoinjectorErenumab-Aooe | 107 | $85,818 |
| XcopriCenobamate | 75 | $84,540 |
| BriviactBrivaracetam | 56 | $78,915 |
| QuliptaAtogepant | 41 | $45,351 |
| RexultiBrexpiprazole | 28 | $40,335 |
| UbrelvyUbrogepant | 40 | $40,063 |
| RytaryCarbidopa/Levodopa | 34 | $36,692 |
| Emgality PenGalcanezumab-Gnlm | 48 | $34,813 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr, Austedo | $1,770 | $339,92229 claims |
| Acadia Pharmaceuticals IncNuplazid | $2,099 | $186,79339 claims |
| PfizerNurtec Odt, Eliquis | $718 | $143,728134 claims |
| UCB, Inc.Briviact, Nayzilam, Neupro | $1,740 | $118,39195 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $502 | $101,33014 claims |
| AbbVieQulipta, Ubrelvy | $3,749 | $85,41481 claims |
| SK Life Science, Inc.Xcopri | $1,602 | $84,54075 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $365 | $40,33528 claims |
| Amneal Pharmaceuticals LLCRytary | $191 | $36,69234 claims |
| MerckBelsomra | $38 | $10,40821 claims |
| Upsher-smith Laboratories LLCTopiramate | $17 | $1,708215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,594 medical providers in Pennsylvania.
Other medical in Greensburg
- Sherry BasileGreensburg$18K
- Marie PirilloGreensburg$14K
- Jacqueline KernaghanSpringfield$426K
- Drew SodaNew Hope$220K
- Angela KapalkoPhiladelphia$123K
- Linda PerryPhiladelphia$123K
- Cory DavidsonErie$119K
- Shelley SassamanTamaqua$90K
- Meghan HoffnerBethlehem$86K
- Thomas IacovoniDanville$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.